Explore our recent Resources

Triangle Insights Group

Explore our recent Resources

Explore Our Recent White Papers

White Paper

White Paper Biopharmaceutical Forecasting: The Latest Perspectives on How to Build Credible, Defensible, and Strategically Actionable Forecasts

Download White Paper
White Paper

White Paper Forecasting Through an Uncertain Access Environment – Building Credible, Defensible Assumptions in a Volatile Policy Era

Download White Paper
White Paper

White Paper New Product Planning: Am I Doing it Right?

Download White Paper
White Paper

White Paper Seizing Early Advantage in a Crowded Oncology Market

Download White Paper
White Paper

White Paper Forecasting Rare Disease: The Benefits of a Market Archetype Approach

Download White Paper
White Paper

White Paper Levers for Launch: Vol. 5 of 5: KADCYLA Case Study

Download White Paper
White Paper

White Paper Levers for Launch: Vol. 4 of 5: VYNDAMAX Case Study

Download White Paper
White Paper

White Paper Levers for Launch: Vol. 3 of 5: REPATHA Case Study

Download White Paper
White Paper

White Paper Levers for Launch: Vol. 2 of 5: NUPLAZID Case Study

Download White Paper
White Paper

White Paper Levers for Launch: Vol 1 of 5: ENTRESTO Case Study

Download White Paper
White Paper

White Paper The Direct-to-Patient Channel in Pharma: A Practical Guide to Protect GTN, Expand Access, and Improve Patient Experience

Download White Paper
White Paper

White Paper The Importance of Early Positioning in Drug Development

Download White Paper
White Paper

White Paper Cell and Gene Therapy in an Evolving Capital Market: Value Drivers to Enable and Elevate a Successful Raise

Download White Paper
White Paper

White Paper Case Study: Unlocking Value through Access Benchmarking

Download White Paper
White Paper

White Paper Biosimilars Commercialization: Lessons Learned from Adalimumab and Four Necessary Approaches

Download White Paper
White Paper

White Paper A Tale of Two Companies: Observations from Back-to-Back Gene Therapy Approvals in Sickle Cell Disease and Implications for Future Innovators

Download White Paper
White Paper

White Paper The Indirect Impacts of the Inflation Reduction Act on Pharmaceutical Pipeline and Portfolio Strategy

Download White Paper
White Paper

White Paper Drug Provisions in the Inflation Reduction Act (IRA): A Critical Consideration for All Therapeutics and Channels

Download White Paper
White Paper

White Paper Data-Driven LCM Contracting Strategy: A Case Study

Download White Paper
Skip to toolbar